Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-May-24 10:00 PM View:  | BioSante Pharmaceuticals, I... (ANIP) | 21-May-24 | Grant | 4,410 | -- | -- | 9% 47.12K to 51.53K | |
| 24-May-23 10:00 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-May-23 | Grant | 6,865 | -- | -- | 17% 40.25K to 47.12K | |
| 29-Apr-22 6:31 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 27-Apr-22 | Grant | 10,049 | -- | -- | 33% 30.2K to 40.25K | |
| 07-Dec-21 4:17 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Dec-21 | Market Purchase | 2,500 | $39.38 | $98,450.00 | 9% 27.7K to 30.2K | 2% |
| 25-Mar-21 4:37 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-21 | Grant | 9,292 | -- | -- | 50% 18.41K to 27.7K | |
| 14-Apr-20 4:34 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 10-Apr-20 | Grant | 7,119 | -- | -- | 63% 11.29K to 18.41K | |
| 05-Mar-20 6:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 04-Mar-20 | Market Purchase | 3,000 | $45.05 | $135,150.00 | 36% 8.29K to 11.29K | |
| 05-Mar-20 6:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 03-Mar-20 | Market Purchase | 2,000 | $45.18 | $90,360.00 | 32% 6.29K to 8.29K | |
| 15-May-19 4:32 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-May-19 | Market Purchase | 2,500 | $69.30 | $173,240.00 | 66% 3.79K to 6.29K | < 1% |
| 01-Apr-19 4:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Mar-19 | Grant | 1,991 | -- | -- | 111% 1.8K to 3.79K | |
| 08-Jun-18 4:02 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Jun-18 | Grant | 1,800 | -- | -- | 100% 0 to 1.8K | |
| 02-Oct-12 4:13 PM View: | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 69,648 | $50.00 | $3,482,400.00 | (99%) 70.55K to 0.9K | |
| 02-Oct-12 4:13 PM View: | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 900 | $50.00 | $45,000.00 | (100%) 0.9K to 0 | |
| 13-Jan-12 5:07 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-12 | Payment of Exercise | 1,017 | $35.65 | $36,256.10 | (1%) 71.56K to 70.55K | (< 1%) |
| 09-Jan-12 6:08 PM View: | Par Pharmaceutical Companie... (PRX) | 06-Jan-12 | Payment of Exercise | 744 | $34.01 | $25,303.40 | (1%) 72.31K to 71.56K | 0% |
| 06-Jan-12 5:03 PM View: | Par Pharmaceutical Companie... (PRX) | 04-Jan-12 | Payment of Exercise | 1,057 | $32.17 | $34,003.70 | (1%) 73.37K to 72.31K | (2%) |
| 22-Nov-11 5:29 PM View: | Par Pharmaceutical Companie... (PRX) | 21-Nov-11 | Payment of Exercise | 6,589 | $29.56 | $194,771.00 | (8%) 79.95K to 73.37K | 1% |
| 11-May-11 6:17 PM View: | Par Pharmaceutical Companie... (PRX) | 10-May-11 | Option Exercise | 26,800 | $13.06 | $350,008.00 | 34% 79.95K to 106.75K | |
| 11-May-11 6:17 PM View: | Par Pharmaceutical Companie... (PRX) | 10-May-11 | Market Option Sale | 26,800 | $35.55 | $952,727.00 | (25%) 106.75K to 79.95K | (< 1%) |
| 11-May-11 5:39 PM View: | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Option Exercise | 68,591 | $10.99 | $753,815.00 | 59% 116.86K to 185.45K | |
| 11-May-11 5:39 PM View: | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Market Option Sale | 100 | $34.47 | $3,447.00 | < 1% 185.45K to 185.55K | 3% |
| 11-May-11 5:39 PM View: | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Market Option Sale | 68,491 | $34.93 | $2,392,650.00 | (37%) 185.55K to 117.06K | (2%) |
| 11-May-11 5:39 PM View: | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Market Sale | 38,002 | $34.93 | $1,327,550.00 | (32%) 117.06K to 79.06K | (2%) |
| 24-Mar-11 5:17 PM View: | Par Pharmaceutical Companie... (PRX) | 22-Mar-11 | Payment of Exercise | 3,064 | $29.00 | $88,856.00 | (3%) 121.02K to 117.96K | < 1% |
| 13-Jan-11 6:14 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-11 | Grant | 21,603 | -- | -- | 18% 119.26K to 140.86K | |
| 13-Jan-11 6:14 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-11 | Payment of Exercise | 19,865 | $35.98 | $714,743.00 | (14%) 140.86K to 121.0K | < 1% |
| 10-Jan-11 5:50 PM View: | Par Pharmaceutical Companie... (PRX) | 06-Jan-11 | Grant | 8,870 | -- | -- | 8% 110.39K to 119.26K | |
| 06-Jan-11 5:53 PM View: | Par Pharmaceutical Companie... (PRX) | 04-Jan-11 | Payment of Exercise | 1,057 | $39.79 | $42,058.00 | (< 1%) 111.45K to 110.39K | 4% |
| 22-Dec-10 1:37 PM View: | Par Pharmaceutical Companie... (PRX) | 20-Dec-10 | Payment of Exercise | 2,640 | $38.26 | $101,006.00 | (2%) 114.09K to 111.45K | (< 1%) |
| 19-Nov-10 5:19 PM View: | Par Pharmaceutical Companie... (PRX) | 18-Nov-10 | Payment of Exercise | 13,179 | $37.72 | $497,112.00 | (10%) 127.27K to 114.09K | 0% |
| 24-Mar-10 12:16 PM View: | Par Pharmaceutical Companie... (PRX) | 22-Mar-10 | Payment of Exercise | 2,359 | $25.09 | $59,187.30 | (2%) 129.62K to 127.27K | (< 1%) |
| 03-Mar-10 5:43 PM View: | Par Pharmaceutical Companie... (PRX) | 02-Mar-10 | Market Sale | 10,756 | $25.46 | $273,834.00 | (8%) 140.38K to 129.62K | 1% |
| 03-Mar-10 5:43 PM View: | Par Pharmaceutical Companie... (PRX) | 01-Mar-10 | Option Exercise | 26,799 | $13.06 | $349,995.00 | 18% 144.88K to 171.68K | |
| 03-Mar-10 5:43 PM View: | Par Pharmaceutical Companie... (PRX) | 01-Mar-10 | Market Option Sale | 26,799 | $25.13 | $673,417.00 | (16%) 171.68K to 144.88K | (< 1%) |
| 03-Mar-10 5:43 PM View: | Par Pharmaceutical Companie... (PRX) | 01-Mar-10 | Market Sale | 4,502 | $25.13 | $113,128.00 | (3%) 144.88K to 140.38K | (< 1%) |
| 12-Jan-10 4:47 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-10 | Payment of Exercise | 3,622 | $25.80 | $93,447.60 | (2%) 148.5K to 144.88K | 0% |
| 06-Jan-10 2:47 PM View: | Par Pharmaceutical Companie... (PRX) | 04-Jan-10 | Grant | 12,631 | -- | -- | 9% 135.78K to 148.41K | |
| 22-Dec-09 2:17 PM View: | Par Pharmaceutical Companie... (PRX) | 22-Dec-09 | Payment of Exercise | 2,033 | $26.04 | $52,939.30 | (1%) 137.82K to 135.78K | (2%) |
| 26-Aug-09 2:22 PM View: | Par Pharmaceutical Companie... (PRX) | 25-Aug-09 | Market Sale | 31,000 | $20.39 | $631,981.00 | (18%) 168.82K to 137.82K | (31%) |
| 24-Mar-09 5:26 PM View: | Par Pharmaceutical Companie... (PRX) | 23-Mar-09 | Payment of Exercise | 2,359 | $11.19 | $26,397.20 | (1%) 171.18K to 168.82K | (125%) |
| 14-Jan-09 4:51 PM View: | Par Pharmaceutical Companie... (PRX) | 12-Jan-09 | Payment of Exercise | 1,017 | $12.59 | $12,804.00 | (< 1%) 172.19K to 171.18K | (111%) |
| 12-Jan-09 5:49 PM View: | Par Pharmaceutical Companie... (PRX) | 09-Jan-09 | Payment of Exercise | 2,743 | $12.83 | $35,192.70 | (2%) 174.94K to 172.19K | (107%) |
| 12-Jan-09 5:49 PM View: | Par Pharmaceutical Companie... (PRX) | 06-Jan-09 | Payment of Exercise | 1,740 | $13.59 | $23,646.60 | (< 1%) 176.68K to 174.94K | (95%) |
| 23-Dec-08 2:57 PM View: | Par Pharmaceutical Companie... (PRX) | 22-Dec-08 | Payment of Exercise | 2,033 | $12.43 | $25,270.20 | (1%) 178.71K to 176.68K | (113%) |
| 20-Nov-08 6:56 PM View: | Par Pharmaceutical Companie... (PRX) | 18-Nov-08 | Grant | 45,496 | -- | -- | 34% 133.21K to 178.71K | |
| 20-Oct-08 5:13 PM View: | Par Pharmaceutical Companie... (PRX) | 17-Oct-08 | Market Purchase | 900 | $10.39 | $9,353.10 | < 1% 132.31K to 133.21K | 133% |
| 20-Oct-08 5:13 PM View: | Par Pharmaceutical Companie... (PRX) | 17-Oct-08 | Market Purchase | 1,500 | $10.41 | $15,612.00 | 1% 130.81K to 132.31K | 133% |
| 26-Mar-08 3:47 PM View: | Par Pharmaceutical Companie... (PRX) | 24-Mar-08 | Payment of Exercise | 2,359 | $18.37 | $43,334.80 | (2%) 133.17K to 130.81K | (21%) |
| 15-Jan-08 4:44 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-08 | Grant | 36,849 | -- | -- | 38% 95.96K to 132.81K | |
| 03-Oct-07 1:55 PM View: | Par Pharmaceutical Companie... (PRX) | 03-Oct-07 | Market Purchase | 2,500 | $18.19 | $45,475.00 | 15% 16.29K to 18.79K | 23% |